Pfizer raised profit estimates for 2025 thanks to cost cuts, despite falling COVID product revenue and patent expirations.
Sanziana Georgescu
Economy
sursa foto: shutterstock.com
Always see our news on Google
Pfizer has announced a revised profit estimate for 2025, underpinned by a cost-cutting program, amid falling COVID product revenues and patent expirations. Shares rose 3.7% after the company reported a better-than-expected quarterly profit. However, Pfizer remains cautious, maintaining annual sales forecasts of between $61 billion and $64 billion, due to pandemic uncertainties and political pressure to cut drug prices.
Sources
Pfizer își majorează estimarea de profit pentru 2025, pe fondul reducerilor masive de costuri și al presiunilor politice din partea lui Trump
Pfizer își ridică prognoza de profit pentru 2025, mizând pe reduceri agresive de costuri și negocieri
Pfizer îşi majorează estimarea de profit pentru 2025, pe fondul reducerilor masive de costuri şi al presiunilor politice din partea lui Trump
Pfizer îşi majorează estimarea de profit pentru 2025, pe fondul reducerilor masive de costuri şi al presiunilor politice din partea lui Trump
Latest News
23:08
Nicușor Dan argues that anyone who repressed during the Revolution has no place in a high position, but Pahonțu is not in this situation.
22:38
A commercial ship caught fire in the Black Sea. Nicușor Dan: It was hit and seems to have sunk.
22:20
Nicușor Dan, after the trilateral meeting in Chișinău: Romania, the Republic of Moldova, and Ukraine will continue collaboration in the fields of infrastructure, energy, and security.
22:01
Péter Magyar: Paks operates at maximum capacity / The nuclear power plant in Romania, previously cited as an example, has been shut down for two weeks.
21:38
UEFA has conducted the draw for the main stage of the Champions League / Liverpool and Real for Chivu
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
